Abbreviations
ALA, alpha lipoic acid; α-MSH, α-melanocyte stimulating hormone;
ACE, angiotensin-converting enzyme blockers; ADHD, attention-deficit
hyperactivity disorder; ARBs, angiotensin II receptor blockers; BBS,
Bardet-Biedl syndrome; BED, binge-eating disorder; BP, blood pressure;
CAIs, carbonic anhydrase inhibitors; CCBs, calcium channel blockers; CNS,
central nervous system; DPP-4, dipeptidyl peptidase-4; FDA, US Food and
Drug Administration; GABA, gamma-aminobutyric; GI, gastrointestinal;
GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-
like peptide-1; HA, headache; HCl, phentermine hydrochloride; HR, heart
rate; IUD, intrauterine device; KATP, ATP-sensitive potassium channel;
LEPR, leptin receptor; MAOI, monoamine oxidase inhibitor; MC4R,
melanocortin-4 receptor; NDRI, norepinephrine-dopamine reuptake
inhibitor; N/V, nausea/vomiting; OCs, oral contraceptives; OTC, over-
the-counter; PCSK1, pproprotein convertase subtilisin/kexin type 1; PO,
by mouth; POMC, proopiomelanocortin; RA, receptor agonist; SGLT2,
sodium-glucose cotransporter 2; SSRIs, selective serotonin reuptake
inhibitors; SU, sulfonylureas; T1DM, type 1 diabetes mellitus; T2DM, type
2 diabetes mellitus; TCA, tricyclic antidepressant; URTI, upper respiratory
tract infection
Source
Tondt J, Orr M, Damian A, Magee J, Okubo N, Manalac R, Othman A,
Karjoo S, Rajpal A, Hooper J, Busse M, Copeland P, Corrado R,
Jain S, Bowlin S, George Jr T, Frederiksen K, Pennings N. Obesity
Algorithm Slides, presented by the Obesity Medicine Association.
www.obesityalgorithm.org. 2026. https://obesitymedicine.org/resources/
obesity-algorithm/. (Accessed = March 2026)
Disclaimer
is resource is for informational purposes only, intended as a quick-reference tool based on the
cited source guideline(s), and should not be used as a substitute for the independent professional
judgment of healthcare providers. Practice guidelines are unable to account for every individual
variation among patients or take the place of clinician judgment, and the ultimate decision
concerning the propriety of any course of conduct must be made by healthcare providers aer
consideration of each individual patient situation. Guideline Central does not endorse any specific
guideline(s) or guideline recommendations and has not independently verified the accuracy hereof.
Any use of this resource or any other Guideline Central resources is strictly voluntary.
1258 Upsala Rd
Sanford, FL 32771
TEL: 407.878.7606
Copyright © 2026
All rights reserved
Obesity Medicine
Association
7173 S. Havana St
#600–130
Centennial, CO 80112
TEL: 303.770.2526
OMAOBEPS03263b
